INHIBIKASE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.41 USD | -7.84% |
|
-16.57% | +11.02% |
| 05/06 | Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline | CI |
| 21/05 | HC Wainwright Adjusts Inhibikase Therapeutics Price Target to $23 From $27, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -7.84% | -16.57% | +11.02% | -62.70% | - | 10.17M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IKT Stock
- Charts Inhibikase Therapeutics, Inc.
- Comparison Chart
